ArticleJournal of clinical medicine2021

Levels of Biosimilar Infliximab during and after Induction Treatment in Crohn's Disease and Ulcerative Colitis-A Prospective Polish Population Study.

Anna Pękala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.